GAIN THERAPEUTICS, INC (GANX)

GAIN THERAPEUTICS, INC (GANX) scores 39 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is $0.00. Quantitative score: 38/100. Qualitative score: 70/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full GANX analysis on boothcheck